Searched for
AUROBINDO PHARMA SHARES
Aurobindo Pharma among 5 stocks hitting 52-week highs; surge up to 18% in a monthFive BSE 200 stocks hit fresh 52-week highs despite a weak market, led by Lenskart, Coforge, Oracle Financial Services Software, Aurobindo ...- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Stocks in news: HDFC Bank, Ola Electric Mobility, NBCC and Knowledge Realty TrustIndian equity markets closed higher on Friday, ending a losing streak with IT stock gains. HDFC Bank's CEO will not seek reappointment, whi...
- Capitalmind Flexi Cap Fund exits Vedanta and 10 others; adds 9 stocksDeepak Shenoy-backed Capitalmind Flexi Cap Fund exited 11 stocks, including Vedanta and Vedanta Oil and Gas, and added nine stocks, includi...
- Quant Mid Cap Fund exits Anthem Biosciences and Lenskart Solutions, adds Cochin Shipyard and 4 others in JulyQuant Mid Cap Fund exited Anthem Biosciences and Lenskart Solutions in July, while adding five new stocks including Cochin Shipyard, UPL an...
- Lenskart Solutions among 7 stocks hitting 52-week highs; surge up to 20% in a monthSeven BSE 200 stocks hit fresh 52-week highs as the Sensex gained 113 points. Paytm led with a 19% monthly rise, followed by Bosch, Lenskar...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Ahead of Market: 10 things that will decide D-Street action on MondayIndian benchmark indices closed lower on Friday as closing auction sessions caused divergence between Sensex and Nifty. While Sensex fell 4...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practicalUS President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...
- Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsIndian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Quant Mid Cap Fund exits Reliance Industries and 3 others, adds BHEL, 1 other stock in JuneQuant Mid Cap Fund exited Reliance Industries and three other stocks in June while adding BHEL and L&T Technology Services to its portfolio...
- Reliance Industries, Groww and MTAR Technologies among stocks bought and sold by mutual funds in JuneMutual funds invested Rs 50,600 crore in stocks during June. They significantly bought JSWInfra, Bajaj Finance, and HDFC Bank. Conversely, ...
- JioBlackRock Flexi Cap Fund exits Vedanta group companies after demerger, sells 8 more stocksJioBlackRock Flexi Cap Fund exited Vedanta group companies following the demerger of the entities in June, according to monthly portfolio d...
- Two Trades for Today: A passenger vehicle maker for a 4.8% upmove, a mid-cap pharma stock for an almost 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
Load More
